Trials / Unknown
UnknownNCT02784366
GI Complications in Cancer Immunotherapy Patients
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to establish a prospective observational cohort of cancer immunotherapy patients with GI side effects in order to identify biomarkers that predict GI complications due to treatment.
Detailed description
Primary objective * To create a data and bio-specimen repository to enhance both safety and efficacy of immunotherapy Secondary objective * Identify biomarkers that may predict GI toxicity in cancer patients undergoing immunotherapy * Define the clinical course of intestinal inflammation and identify genetic factors of therapeutic response to GI medications * Analyze genotype-phenotype correlations in GI side effects in patients undergoing cancer immunotherapy
Conditions
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2024-03-01
- Completion
- 2024-03-01
- First posted
- 2016-05-27
- Last updated
- 2022-04-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02784366. Inclusion in this directory is not an endorsement.